Fibrinogen/LDL apheresis for treatment of sudden hearing loss : An observational study on 152 patients;H.E.L.P.-apherese bei der Behandlung des Hörsturzes : Eine Anwendungsbeobachtung an 152 Patienten

HNO

Volumn 56, Issue 9, 2008, Pages 961-966

  Canis, M ^a   Heigl, F ^b   Hettich, R ^b   Osterkorn, D ^c   Osterkorn, K ^c   Suckfuell, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Dres Heigl Hettich und Partner   (Germany)

^c Medizinisches Wirtschaftsinstitut   (Germany)

Author keywords

Apheresis; Case series; Cochlear microcirculation; Remission rate; Sudden sensorineural hearing loss

Indexed keywords

FIBRINOGEN; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; SUDDEN DEAFNESS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT REMOVAL; FEMALE; FIBRINOGEN; HEARING LOSS, SUDDEN; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51649127667     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-008-1818-7     Document Type: Article

References (34)

1. Axelsson A, Lindgren F (1985) Is there a relationship between hypercholesterolaemia and noise-induced hearing loss? Acta Otolaryngol 100: 379-386
2. Byl FM (1977) Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope 87: 817-825
3. Byl FM jr (1984) Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 94: 647-661
4. Feron O, Dessy C, Desager JP, Balligand JL (2001) Hydroxy-methylglutaryl- coenzyme a reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103: 113-118
5. Fessenden JD, Schacht J (1998) The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology. Hear Res 118: 168-176
6. Friedrich G, Wolf G (1984) Prognostisch relevante Faktoren beim Hörsturz. HNO 32: 74-80
7. Fuortes LJ, Tang S, Pomrehn P, Anderson C (1995) Prospective evaluation of associations between hearing sensitivity and selected cardiovascular risk factors. Am J Ind Med 28: 275-280
8. Gratton MA, Wright CG (1992) Alterations of inner ear morphology in experimental hypercholesterolemia. Hear Res 61: 97-105
9. Hesse G, Hesch RD (1986) Evaluation of risk factors in various forms of inner ear hearing loss. HNO 34: 503-507
10. Kashiwado I, Hattori Y, Qiao Y (1994) Functional and morphological changes in the cochlea of cholesterol fed guinea pigs. Nippon Ika Daigaku Zasshi 61: 321-329
11. Lehr HA, Hubner C, Nolte D et al. (1991) Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo. Res Exp Med (Berl) 191: 85-90
12. Michel O, Klemm E (1997) Hörsturz. HNO Information 3
13. Miller JM, Ren TY, Nuttall AL (1995) Studies of inner ear blood flow in animals and human beings. Otolaryngol Head Neck Surg 112: 101-113
14. Morizono T, Paparella MM (1978) Hypercholesterolemia and auditory dysfunction. Experimental studies. Ann Otol Rhinol Laryngol 87: 804-814
15. Morizono T, Sikora MA (1982) Experimental hypercholesterolemia and auditory function in the chinchilla. Otolaryngol Head Neck Surg 90: 814-818
16. Nguyen TV, Brownell WE (1998) Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Otolaryngol Head Neck Surg 119: 14-20
17. Olzowy B, Osterkorn D, Suckfull M (2005) The incidence of sudden hearing loss is greater than previously assumed. MMW Fortschr Med 47: 37-38
18. Preyer S, Baisch A, Bless D, Gummer AW (2001) Distortion product otoacoustic emissions in human hypercholesterolemia. Hear Res 152: 139-151
19. Rosen S, Bergman M, Plester D et al. (1962) Presbycusis study of a relatively noise-free population in the Sudan. Trans Am Otol Soc 50: 135-152
20. Rosen S, Olin P, Rosen HV (1970) Diery prevention of hearing loss. Acta Otolaryngol 70: 242-247
21. Rudack C, Langer C, Stoll W et al. (2006) Vascular risk factors in sudden hearing loss. Thromb Haemost 95: 454-461
22. Saito T, Sato K, Saito H (1986) An experimental study of auditory dysfunction associated with hyperlipoproteinemia. Arch Otorhinolaryngol 243: 242-245
23. Satar B, Ozkaptan Y, Surucu HS, Ozturk H (2001) Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol 22: 786-789
24. Sikora MA, Morizono T, Ward WD et al. (1986) Diet-induced hyperlipidemia and auditory dysfunction. Acta Otolaryngol 102: 372-381
25. Spencer JT jr (1973) Hyperlipoproteinemias in the etiology of inner ear disease. Laryngoscope 83: 639-678
26. Suckfull M (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360: 1811-1817
27. Suckfull M, Thiery J, Wimmer C et al. (1997) Hypercholesteremia and hyperfibrinogenemia in sudden deafness. Laryngorhinootologie 76: 453-457
28. Suzuki K, Kaneko M, Murai K (2000) Influence of serum lipids on auditory function. Laryngoscope 110: 1736-1738
29. Ullrich D, Aurbach G, Drobik C (1992) A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 249: 273-276
30. Wei BP, Mubiru S, O'Leary S (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev CD003998
31. Xenellis J, Karapatsas I, Papadimitriou N et al. (2006) Idiopathic sudden sensorineural hearing loss: prognostic factors. J Laryngol Otol 120: 718-724
32. Zadeh MH, Storper IS, Spitzer JB (2003) Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 128: 92-98
33. Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 92: 652-662
34. Kubo T, Matsunaga T, Asai H et al. (1988) Efficacy of defibrogenation and steroid therapy on sudden deafness. Arch Otolaryngol Head Neck Surg 114: 649-652